Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)
Addex Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(5.1%),New Enterprise Associates 15, L.P.(5.1%)等
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 424B3:募资说明书
Addex Therapeutics | EFFECT:其他
Addex Therapeutics | POS AM:修改注册声明表
Addex Therapeutics | 20-F:2023财年年报
Addex Therapeutics | 6-K:外国发行人报告(业绩相关)
Addex Therapeutics | 6-K:外国发行人报告
Addex Therapeutics | 424B5:募资说明书